๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Targeted Therapy

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer NCT07290621Phase 21 site๐Ÿ“ Chicago University of Chicago ยท Tests: Toripalimab, Carboplatin, Paclitaxel Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC NCT06876753n/a2 sites๐Ÿ“ Nanjing๐Ÿ“ Nanjing Zhongda Hospital Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma NCT07359014NA1 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Dual CD19/BCMA CAR-T A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany NCT07255638n/a12 sites๐Ÿ“ Berlin๐Ÿ“ Bochum๐Ÿ“ Deggendorf Blueprint Medicines Corporation ยท Tests: Avapritinib GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer NCT07489287Phase 11 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: GB-5267 - IV only, GB-5267 -Combined IV and IP Infusion Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma NCT07832006Phase 21 site๐Ÿ“ Beijing Shunda Du ยท Tests: Irreversible Electroporation, Lenvatinib, Sintilimab Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke NCT07069452n/a1 site๐Ÿ“ Gonesse Centre Hospitalier de Gonesse TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCC NCT07658833n/a1 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: TACE (transarterial chemoembolization) combined with targeted/immunotherapy Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies NCT07284433Phase 1, Phase 213 sites๐Ÿ“ Chicago๐Ÿ“ Evanston๐Ÿ“ Providence AvenCell Therapeutics, Inc. ยท Tests: Cyclophosphamide (Non-IMP, Lymphodepletion), Fludarabine (Non-IMP, Lymphodepletion), Allo-QuadCAR01-T Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC NCT07500220Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-G3B7-NK dual-target CAR-NK cells, Fludarabine, Cyclophosphamide CS-121 APOC3 Base Editing in FCS NCT07176923EARLY Phase 11 site๐Ÿ“ Hefei CorrectSequence Therapeutics Co., Ltd ยท Tests: CS-121 Colorectal Cancer Real-world Outcomes Study of Survival With Immunomodulator Plus Standard Anti-cancer Therapies NCT07703709n/a1 site๐Ÿ“ Taichung Chou-Chen Chen RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma NCT07150806Phase 1, Phase 21 site๐Ÿ“ Columbus Joshua Palmer ยท Tests: Actinium Ac 225 DOTATATE RYZ101, Biospecimen Collection, Computed Tomography, Echocardiography Test, Gallium Ga 68-DOTAโ€ฆ Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC NCT07145450Phase 1, Phase 210 sites๐Ÿ“ Copenhagen๐Ÿ“ Berlin๐Ÿ“ Dresden Anocca AB ยท Tests: ANOC-001 (TCR-T cells targeting KRAS G12V mutation presented by specific HLA alleles), ANOC-002 (TCR-T cells targeting โ€ฆ Sleep Mechanisms Of Regulating Emotions NCT06373718NA1 site๐Ÿ“ Palo Alto Stanford University ยท Tests: Cognitive Behavioral Therapy for Insomnia Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations NCT07032727Phase 22 sites๐Ÿ“ Miami๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Olutasidenib, Cladribine (CLAD), Venetoclax, Gilteritinib, Ruxolitinib Characterization of the Cytokine Profile and the Microbiome in Darier's Disease NCT06614777NA1 site๐Ÿ“ Toulouse University Hospital, Toulouse ยท Tests: skin biopsies and blood extraction Treatment of Borderline Personality Disorder With rTMS NCT07197502NA2 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles University of California, Los Angeles ยท Tests: Transcranial Magnetic Stimulation (TMS) CAR-T Therapy for Refractory Autoimmune Diseases NCT07059169NA1 site๐Ÿ“ Wuhan LiangZou ยท Tests: JY231 (JY231 injection) Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL NCT06481228NA1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: CAR-T cells, Venetoclax, Olverembatinib CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy NCT06135909n/a1 site๐Ÿ“ Beijing Chinese Pulmonary Vascular Disease Research Group Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma NCT07627698Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells, Fludarabine, Cyclophosphamide GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFฮฒ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers NCT03198052Phase 12 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: CAR-T cells targeting GPC3, Mesothelin, Claudin18.2, GUCY2C, B7-H3, PSCA, PSMA, MUC1, TGFฮฒ, HER2, Lewis-Y, AXL, or EGFR IVIG for Infection Prevention After CAR-T-Cell Therapy NCT05952804Phase 27 sites๐Ÿ“ Duarte๐Ÿ“ Miami๐Ÿ“ Tampa Fred Hutchinson Cancer Center ยท Tests: Immune Globulin Infusion (Human), 10% Solution, Anti-CD19 CAR T Cells Preparation, Saline, Biospecimen Collection, Survโ€ฆ Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment NCT07197801NA1 site๐Ÿ“ Danville Geisinger Clinic ยท Tests: Peer recovery support to enhance patient engagement in medication for opioid use disorder treatment The Drug Rediscovery Protocol (DRUP Trial) NCT02925234Phase 236 sites๐Ÿ“ Alkmaar๐Ÿ“ Almelo๐Ÿ“ Amersfoort The Netherlands Cancer Institute ยท Tests: Panitumumab, Olaparib, Dabrafenib, Nilotinib, Trametinib A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus NCT07444307Phase 13 sites๐Ÿ“ Hefei๐Ÿ“ Wuhan๐Ÿ“ Beijing Hangzhou Qihan Biotech Co., Ltd. ยท Tests: QT-019B Cell Injection Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer NCT06521866Phase 210 sites๐Ÿ“ Fuzhou๐Ÿ“ Xiamen๐Ÿ“ Lanzhou Fudan University ยท Tests: Serplulimab, Chemotherapy, SABR, Targeted therapy Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1๏ผŒChemotherapy and Target Therapy for Metastatic Colorectal Cancer NCT06841159Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: Ultra-fractionated radiation therapy, Sintilimab, Standard systemic therapy CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed โ‰ฅ3 Lines of Therapy. NCT06733610Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: universal allogeneic anti-CD19/BCMA CAR T-cells
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy